Nasdaq Edges Higher, Continuing Climb

[ad_1] The Nasdaq Composite climbed for a third consecutive day as shares of Nvidia, Amazon.com and Google parent Alphabet advanced. The tech-heavy index added 0.1%, leaving it down 1% in…

UnitedHealth Group to Sell Operations in Brazil

[ad_1] UnitedHealth Group has agreed to sell its operations in Brazil to a private investor. The healthcare and insurance company disclosed Friday that it expects to close the sale in…

The Dow Jones Industrial Average Is So Back. Here Are the Stocks Sending It to New Highs.

[ad_1] The Dow Jones Industrial Average is poised to become the first major U.S. stock index to set a record since the Federal Reserve started raising interest rates. Investors on…

The Medicare Gold Rush Is Slowing Down

[ad_1] The popularity of private Medicare plans has been a huge driver of profits for insurance companies in recent years. There are signs the gold rush isn’t quite what it…

UnitedHealth Group Incorporated (NYSE:UNH) is Lombard Odier Asset Management Switzerland SA’s 3rd Largest Position

[ad_1] Lombard Odier Asset Management Switzerland SA increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 28.9% in the second quarter, according to the company…

Cigna-Humana Merger Is Likely to Face Antitrust Challenge

[ad_1] From a financial perspective, a Cigna-Humana megamerger makes a lot of sense.  Cigna has a huge pharmacy benefit management business, but has been largely missing out on the highly…

Senators Call for Investigation of Health Insurers’ Role in Driving Up Drug Costs

[ad_1] A pair of U.S. senators called on the federal government to investigate health insurers that are paying high prices for generic drugs for serious diseases like cancer and multiple…

WSJ News Exclusive | Senators Call for Investigation of Health Insurers’ Role in Driving Up Drug Costs

[ad_1] A pair of U.S. senators called on the federal government to investigate health insurers that are paying high prices for generic drugs for serious diseases like cancer and multiple…

Ozempic Boom Is an Opportunity for Health Insurers

[ad_1] You would think a new class of high-price weight loss drugs taken by millions of Americans would be a problem for health insurers. After all, they ultimately foot the…

This Out-of-Favor Sector Is Benefiting From Higher Rates

[ad_1] Health insurers are earning more on their investments, partly offsetting higher procedure volumes. [ad_2] Source link